Membrane microparticles: shedding new light into cancer cell communication

Paloma Silva de Souza1, Roberta Soares Faccion1, Paula Sabbo Bernardo2

  • 1Laboratório de Hemato-Oncologia Celular e Molecular, Programa de Hemato-Oncologia Molecular, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Abstract

Insights

Microparticles (MPs), small cell fragments, carry oncogenic molecules that promote cancer progression and drug resistance. This review details MP cargo, their role in activating cancer pathways, and their impact on treatment resistance.

Area of Science:

  • Cell biology
  • Cancer research
  • Molecular oncology

Background:

  • Microparticles (MPs) are cell-derived vesicles containing oncogenic proteins and nucleic acids.
  • MPs facilitate intercellular transfer of cancer-promoting molecules.
  • These molecules contribute to cancer cell survival, drug resistance, and metastasis.

Purpose of the Study:

  • To review current knowledge on MP biogenesis and their role in cancer.
  • To discuss specific RNA and protein cargo within MPs.
  • To explore MP-mediated signaling in recipient cells and their impact on cancer progression and treatment.

Main Methods:

  • Literature review of studies on microparticles in cancer.
  • Analysis of identified oncogenic molecules within MPs (proteins, mRNAs, microRNAs).
  • Examination of MP cargo transfer and its effects on recipient cells and cancer pathways.

Main Results:

  • MPs contain diverse oncogenic cargo, including proteins like XIAP and survivin, and microRNAs such as miR-21.
  • MPs transfer cargo to various cell types, activating oncogenic pathways.
  • Stromal cell-derived MPs can induce chemoresistance and invasiveness in cancer cells.

Conclusions:

  • MPs play a significant role in cancer development and progression.
  • Understanding MP cargo and biogenesis is crucial for cancer therapy.
  • MPs represent a potential therapeutic target for overcoming drug resistance and metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
Cell-surface Signaling01:21

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
57.9K